These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 33460316)

  • 21. [TREATMENT OF AGE-RELATED ANDROGEN DEFICIENCY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA].
    Kaprin AD; Kostin AA; Vinogradov IV; Magamadov EL
    Urologiia; 2015; (1):79-80, 82. PubMed ID: 26094393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-onset hypogonadism a challenging task for the andrology field.
    Corona G; Krausz C
    Andrology; 2020 Nov; 8(6):1504-1505. PubMed ID: 33460316
    [No Abstract]   [Full Text] [Related]  

  • 23. Critical evaluation of different available guidelines for late-onset hypogonadism.
    Giagulli VA; Castellana M; Lisco G; Triggiani V
    Andrology; 2020 Nov; 8(6):1628-1641. PubMed ID: 32593233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternatives to testosterone replacement: testosterone restoration.
    McCullough A
    Asian J Androl; 2015; 17(2):201-5. PubMed ID: 25578932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Androgenic treatment of male hypogonadism].
    Kuhn JM; Prévost G
    Presse Med; 2014 Feb; 43(2):196-204. PubMed ID: 24268959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional hypogonadism in middle-aged and older men: testosterone treatment or not?
    Grossmann M; Jones TH
    Eur J Endocrinol; 2021 Aug; 185(3):D1-D9. PubMed ID: 34260411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-onset hypogonadism: Prostate safety.
    Miranda EP; Torres LO
    Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late-onset male hypogonadism and testosterone replacement therapy in primary care.
    Brunton SA; Sadovsky R
    J Fam Pract; 2010 Jul; 59(7 Suppl):S1-8. PubMed ID: 20625573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone therapy in women with androgen deficiency: Its time has come.
    Guay A; Traish A
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1116-26. PubMed ID: 20872314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone and benign prostatic hyperplasia.
    Jarvis TR; Chughtai B; Kaplan SA
    Asian J Androl; 2015; 17(2):212-6. PubMed ID: 25337845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-onset hypogonadism: a concept comes of age.
    Nieschlag E
    Andrology; 2020 Nov; 8(6):1506-1511. PubMed ID: 31639279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies in testosterone replacement therapy: testosterone and cardiovascular disease.
    Hwang K; Miner M
    Asian J Androl; 2015; 17(2):187-91. PubMed ID: 25652628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late-onset Hypogonadism: Bone health.
    Rochira V
    Andrology; 2020 Nov; 8(6):1539-1550. PubMed ID: 32469467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current topics in testosterone replacement of hypogonadal men.
    Nieschlag E
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis.
    Kang DY; Li HJ
    Medicine (Baltimore); 2015 Jan; 94(3):e410. PubMed ID: 25621688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the basis of sexual dysfunction during late-onset hypogonadism.
    Tharakan T; Miah S; Jayasena C; Minhas S
    F1000Res; 2019; 8():. PubMed ID: 30984376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.